Earnings Ahead

ALNY - Alnylam Pharmaceuticals, Inc.

188.8 -2.55 -1.33

Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

About

Profile


Headquarters

Cambridge, Massachusetts, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

ALNY



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Alnylam posts Q4 topline miss; pushes back key data readout
  • Alnylam Pharmaceuticals Non-GAAP EPS of -$0.77 in-line, revenue of $439.72M misses by $2.58M
  • Alnylam Pharmaceuticals Q4 2023 Earnings Preview
  • Investors growing more bullish on SMID cap biotech stocks
  • Regeneron eyes Wegovy combo to improve quality of weight loss
  • Alnylam reports preliminary Q4 global net product revenues
  • U.S. strong buy ideas for the next 12 months – according to Citi
  • Biotechs post record gains in November amid improving outlook
  • Alnylam reports positive Phase 2 data for hypertension drug
  • Alnylam Pharmaceuticals beats Q3 top and bottom line estimates; updates FY23 outlook
  • Alnylam Pharmaceuticals Q3 2023 Earnings Preview
  • Alnylam downgraded at Oppenheimer ahead of key data readout
  • Alnylam sends Arbutus lower after FDA snub for amyloidosis drug
  • Alnylam U.S. label expansion for amyloidosis drug denied
  • Ionis, AbbVie, Alnylam draw bullish views at Raymond James
  • Citi says concerns over FDA approval of Alnylam drug are "overdone"
  • Alnylam stock falls after FDA panel questions drug's effectiveness
  • Alnylam wins FDA panel backing additional Onpattro indications
  • Alnylam stock trading halted as FDA AdCom meets on amyloidosis drug
  • Alnylam amyloidosis drug led to “small” benefits in Phase 3 trial: FDA
PEERS
/XLV

XLV

Earnings History

Date EPS / Forecast Revenue / Forecast
February 10, 2022 -2.16 / -1.56 258.54M / 232.49M Beat!
October 28, 2021 -1.72 / -1.54 187.63M / 218.72M
August 3, 2021 -1.61 / -1.61 220.55M / 192.05M Beat!
April 29, 2021 -1.71 / -1.75 177.57M / 168.5M Beat!
February 11, 2021 -2.09 / -1.78 163.56M / 146.64M Beat!
November 5, 2020 -2.18 / -1.63 125.85M / 119.05M Beat!
August 6, 2020 -1.56 / -1.72 103.96M / 98.76M Beat!
May 6, 2020 -1.62 / -1.89 99.48M / 91.74M Beat!
February 6, 2020 -2.47 / -2.21 71.68M / 71.6M Beat!
October 31, 2019 -1.92 / -2.07 70.06M / 57.17M Beat!
Date Price Open High Low Vol Change ER
Oct 9, 2023 168.32 170.63
173.3
159.47
1.5M -4.86%
Oct 6, 2023 176.92 178.42
180.99
176.74
460K -1%
Oct 5, 2023 178.71 167.92
178.99
167.92
550K 5.64%
Oct 4, 2023 169.17 172.52
172.52
167.4
654K -2.16%
Oct 3, 2023 172.91 178.17
179.91
172.48
558K -3.38%
 
Oct 2, 2023 178.96 177.31
179.3
176
630K 1.05%
Sep 29, 2023 177.1 175.74
177.85
174.07
754K 1.76%
Sep 28, 2023 174.03 176.32
178.24
173.9
359K -1.6%
Sep 27, 2023 176.86 177.18
178.55
171.66
512K 1.03%
Sep 26, 2023 175.05 171.01
175.41
170.05
577K 2.51%
Sep 25, 2023 170.77 170.93
172.31
168.65
500K -0.45%
Sep 22, 2023 171.55 173.85
175.22
169.85
679K -1.32%
Sep 21, 2023 173.85 174.47
175.39
171.08
685K -0.95%
Sep 20, 2023 175.52 176
179.49
174.41
565K -0.08%
Sep 19, 2023 175.66 179.02
180.32
175.41
658K -2.29%
Sep 18, 2023 179.77 183.62
184.84
178.21
731K -2.82%
Sep 15, 2023 184.99 191.64
196.28
182.63
1.9M -4.18%
Sep 14, 2023 193.06 200
202.5
188.45
2.1M -8.78%
Sep 12, 2023 211.65 204.24
212.08
202.87
765K 3.89%
Sep 11, 2023 203.72 201.57
204.65
196.67
554K 1.14%
Sep 8, 2023 201.43 201.25
205.52
200.52
660K 0.16%
Sep 7, 2023 201.1 201.14
203.79
200.18
636K -0.17%
Sep 6, 2023 201.45 201.5
201.76
197.03
395K 0.55%
Sep 5, 2023 200.34 200.83
204.59
199.26
436K -0.41%
Sep 1, 2023 201.17 199.14
204.48
199.14
494K 1.69%
Aug 31, 2023 197.82 197.5
200.77
197.15
464K 0.33%
Aug 30, 2023 197.16 194.46
198.34
194.46
436K 1.39%
Aug 29, 2023 194.46 191.67
195.7
190.97
368K 1.46%
Aug 28, 2023 191.66 189.99
192.71
189.76
267K 1.27%
Aug 25, 2023 189.26 186.55
190.5
186.38
193K 1.33%
Aug 24, 2023 186.77 189.72
190.32
183.73
350K -1.9%
Aug 23, 2023 190.38 190.4
192.4
189.07
270K 0.53%
Aug 22, 2023 189.38 189.13
190.38
187.62
412K 0.34%
Aug 21, 2023 188.73 186.7
189.43
183.41
352K 1.45%
Aug 18, 2023 186.03 182.19
186.25
181.87
373K 1.16%
Aug 17, 2023 183.89 183.13
185.4
182.36
396K 0.80%
Aug 16, 2023 182.43 179.35
182.96
179
420K 1.28%
Aug 15, 2023 180.13 180
181.67
178.64
499K -0.67%
Aug 14, 2023 181.35 184.41
184.41
180.76
1.1M -2.39%
Aug 11, 2023 185.79 184.11
187.45
184.11
359K 0.41%
Aug 10, 2023 185.03 188.02
189.54
184.99
319K -0.71%
Aug 9, 2023 186.36 186.19
186.67
183.87
367K 0.82%
Aug 8, 2023 184.84 184.54
186.9
182.72
488K 0.30%
Aug 7, 2023 184.29 185.61
186.03
182.77
452K -0.7%
Aug 4, 2023 185.58 189.31
189.31
184.01
568K -2.38%
Aug 3, 2023 190.1 182.13
192.29
180.02
632K 1.65%
Aug 2, 2023 187.01 186.8
187.5
184.16
626K -1.08%
Aug 1, 2023 189.05 193.4
194.52
187.47
507K -3.25%
Jul 31, 2023 195.4 199.1
200.29
194.52
406K -1.95%
Jul 28, 2023 199.29 196.59
200
194.89
342K 2.27%
Jul 27, 2023 194.87 196.18
196.54
192.58
745K -0.04%
Jul 26, 2023 194.94 193.42
195.24
190.05
460K 0.77%
Jul 25, 2023 193.46 192.06
195.13
190.76
686K 0.59%
Jul 24, 2023 192.32 201.19
202.46
190.86
770K -3.87%
Jul 21, 2023 200.07 201.89
202.36
199.36
305K -0.68%
Jul 20, 2023 201.44 204.33
206.57
200
440K -1.89%
Jul 19, 2023 205.32 209.97
210.56
205.29
428K -1.49%
Jul 18, 2023 208.42 202.77
210.76
200.13
600K 2.76%
Jul 17, 2023 202.83 208
218.88
201.86
1.2M 2.91%
Jul 14, 2023 197.1 203.54
203.88
196.9
498K 0%